Home/Filings/4/0000950170-24-114193
4//SEC Filing

Chaturvedi Pravin R 4

Accession 0000950170-24-114193

CIK 0001585608other

Filed

Oct 9, 8:00 PM ET

Accepted

Oct 10, 9:57 PM ET

Size

8.0 KB

Accession

0000950170-24-114193

Insider Transaction Report

Form 4
Period: 2024-10-08
Chaturvedi Pravin R
Chief Scientific Officer
Transactions
  • Award

    Common Stock

    2024-10-08+4,9224,957 total
  • Award

    Stock option (right to buy)

    2024-10-08+39,37639,376 total
    Exercise: $1.29Exp: 2034-10-08Common Stock (37,376 underlying)
Footnotes (5)
  • [F1]Granted pursuant to the issuer's 2014 Stock Incentive Plan.
  • [F2]The option and restricted stock unit grants were approved by the issuer's board of directors on October 8, 2024.
  • [F3]Each restricted stock unit represents a contingent right to receive one share of the issuer's voting common stock. The restricted stock units vest in three equal annual installments beginning on October 8, 2025. Vested shares will be delivered to the reporting person on the vesting date or dates provided in the grant notice.
  • [F4]On May 23, 2024, the issuer effected a 60-for-1 reverse stock split of the issued and outstanding shares of its voting common stock (the " Reverse Stock Split). Upon effectiveness of the Reverse Stock Split, every 60 shares of voting common stock was automatically converted into one share of voting common stock.
  • [F5]The options will vest ratably on a monthly basis over 36 months from the grant date, so long as the executive remains employed by the issuer.

Documents

1 file

Issuer

Jaguar Health, Inc.

CIK 0001585608

Entity typeother

Related Parties

1
  • filerCIK 0001916935

Filing Metadata

Form type
4
Filed
Oct 9, 8:00 PM ET
Accepted
Oct 10, 9:57 PM ET
Size
8.0 KB